BACKGROUND. Isolated deficiencies of antithrombin III, protein C, protein S, and plasminogen have been implicated as a cause of deep-vein thrombosis. It is assumed that patients with recurrent, familial, or juvenile thrombosis are very likely to have such a deficiency. METHODS. We studied the prevalence of isolated deficiencies of these proteins in 277 consecutive outpatients with venographically proved acute deep-vein thrombosis, as compared with 138 age-matched and sex-matched controls without deep-vein thrombosis, and calculated the positive predictive value of a history of recurrent, familial, or juvenile venous thromboembolism for the presence of such a deficiency. RESULTS. The overall prevalence of deficiencies of any of these proteins in the patients with venous thrombosis was 8.3 percent (23 of 277 patients) (95 percent confidence interval, 5.4 to 12.4), as compared with 2.2 percent in the controls (3 of 138 subjects) (95 percent confidence interval, 0.5 to 6.1; P less than 0.05 for the comparison between groups). The positive predictive values for the presence of an isolated protein deficiency in patients with recurrent, familial, or juvenile deep-vein thrombosis, defined as the proportion of patients with the clinical finding who had a deficiency of one or more of the proteins, were 9, 16, and 12 percent, respectively. CONCLUSIONS. The cause of acute venous thrombosis in most outpatients (91.7 percent) cannot be explained by abnormalities of coagulation-inhibiting and fibrinolytic proteins. The information obtained from the medical history concerning recurrent or familial venous thrombosis or the onset of the disease at a young age is not useful for the identification of patients with protein deficiencies.
Source Information
Center for Thrombosis, Haemostasis, and Atherosclerosis Research, Academic Medical Center, Amsterdam, The Netherlands.
This article has been cited by other articles:
Seguin, C., Kassis, J., Busque, L., Bestawros, A., Theodoropoulos, J., Alonso, M.-L., Harvey, E. J.
(2008). Non-traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation but not thrombophilia. Rheumatology (Oxford)
47: 1151-1155
[Abstract][Full Text]
Dahlback, B.
(2008). Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood
112: 19-27
[Abstract][Full Text]
Stone, M. E., Silverman, S. H., Nomoto, K.
(2007). Intracardiac Thrombosis and Acute Right Ventricular Failure Following Complex Reoperative Cardiac Surgery With Aprotinin and Deep Hypothermic Circulatory Arrest. SEMIN CARDIOTHORAC VASC ANESTH
11: 177-184
[Abstract]
van Vlijmen, E. F. W., Brouwer, J.-L. P., Veeger, N. J. G. M., Eskes, T. K. A. B., de Graeff, P. A., van der Meer, J.
(2007). Oral Contraceptives and the Absolute Risk of Venous Thromboembolism in Women With Single or Multiple Thrombophilic Defects: Results From a Retrospective Family Cohort Study. Arch Intern Med
167: 282-289
[Abstract][Full Text]
Morozowich, S. T., Donahue, B. S., Welsby, I. J.
(2006). Genetics of coagulation: considerations for cardiac surgery.. SEMIN CARDIOTHORAC VASC ANESTH
10: 297-313
[Abstract]
Kuhli, C., Jochmans, K., Scharrer, I., Luchtenberg, M., Hattenbach, L.-O.
(2006). Retinal Vein Occlusion Associated With Antithrombin Deficiency Secondary to a Novel G9840C Missense Mutation.. Arch Ophthalmol
124: 1165-1169
[Abstract][Full Text]
Stamou, K. M., Toutouzas, K. G., Kekis, P. B., Nakos, S., Gafou, A., Manouras, A., Krespis, E., Katsaragakis, S., Bramis, J.
(2006). Prospective Study of the Incidence and Risk Factors of Postsplenectomy Thrombosis of the Portal, Mesenteric, and Splenic Veins. Arch Surg
141: 663-669
[Abstract][Full Text]
Pottier, P., Cormier, G., Truchaud, F., Planchon, B.
(2005). Efficiency of Systematic Thrombophilia Screening in Idiopathic Venous Thrombosis: A Prospective Study in Internal Medicine. CLIN APPL THROMB HEMOST
11: 243-251
[Abstract]
Rosendaal, F. R.
(2005). Venous Thrombosis: The Role of Genes, Environment, and Behavior. ASH Education Book
2005: 1-12
[Abstract][Full Text]
Caprini, J. A., Glase, C. J., Anderson, C. B., Hathaway, K.
(2004). Laboratory Markers in the Diagnosis of Venous Thromboembolism. Circulation
109: I-4-I-8
[Abstract][Full Text]
McBane, R. D. II
(2003). Genetically Determined Procoagulant States and Heparin Use. SEMIN CARDIOTHORAC VASC ANESTH
7: 427-442
[Abstract]
Erbe, M., Rickerts, V., Bauersachs, R. M., Lindhoff-Last, E.
(2003). Acquired Protein C and Protein S Deficiency in HIV-Infected Patients. CLIN APPL THROMB HEMOST
9: 325-331
[Abstract]
Picard, V., Dautzenberg, M.-D., Villoutreix, B. O., Orliaguet, G., Alhenc-Gelas, M., Aiach, M.
(2003). Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis. Blood
102: 919-925
[Abstract][Full Text]
Anderson, F. A. Jr., Spencer, F. A.
(2003). Risk Factors for Venous Thromboembolism. Circulation
107: I-9-16
[Abstract][Full Text]
Cosmi, B., Legnani, C., Bernardi, F., Coccheri, S., Palareti, G.
(2003). Role of Family History in Identifying Women With Thrombophilia and Higher Risk of Venous Thromboembolism During Oral Contraception. Arch Intern Med
163: 1105-1109
[Abstract][Full Text]
Folsom, A. R., Aleksic, N., Wang, L., Cushman, M., Wu, K. K., White, R. H.
(2002). Protein C, Antithrombin, and Venous Thromboembolism Incidence: A Prospective Population-Based Study. Arterioscler. Thromb. Vasc. Bio.
22: 1018-1022
[Abstract][Full Text]
Bauer, K. A., Rosendaal, F. R., Heit, J. A.
(2002). Hypercoagulability: Too Many Tests, Too Much Conflicting Data. ASH Education Book
2002: 353-368
[Abstract][Full Text]
Middeldorp, S., Meinardi, J. R., Koopman, M. M.W., van Pampus, E. C.M., Hamulyak, K., van der Meer, J., Prins, M. H., Buller, H. R.
(2001). A Prospective Study of Asymptomatic Carriers of the Factor V Leiden Mutation To Determine the Incidence of Venous Thromboembolism. ANN INTERN MED
135: 322-327
[Abstract][Full Text]
Bauer, K. A.
(2001). The Thrombophilias: Well-Defined Risk Factors with Uncertain Therapeutic Implications. ANN INTERN MED
135: 367-373
[Abstract][Full Text]
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W.M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., Rosendaal, F. R.
(2001). Oral Contraceptives and the Risk of Venous Thrombosis. NEJM
344: 1527-1535
[Full Text]
Federman, D. G., Kirsner, R. S.
(2001). An Update on Hypercoagulable Disorders. Arch Intern Med
161: 1051-1056
[Abstract][Full Text]
Seligsohn, U., Lubetsky, A.
(2001). Genetic Susceptibility to Venous Thrombosis. NEJM
344: 1222-1231
[Full Text]
(2000). Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J
21: 1301-1336
Junker, R., Koch, H.-G., Auberger, K., Munchow, N., Ehrenforth, S., Nowak-Gottl, U.
(1999). Prothrombin G20210A Gene Mutation and Further Prothrombotic Risk Factors in Childhood Thrombophilia. Arterioscler. Thromb. Vasc. Bio.
19: 2568-2572
[Abstract][Full Text]
Salomon, O., Steinberg, D. M., Zivelin, A., Gitel, S., Dardik, R., Rosenberg, N., Berliner, S., Inbal, A., Many, A., Lubetsky, A., Varon, D., Martinowitz, U., Seligsohn, U.
(1999). Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous Thromboembolism : Prevalence and Risk Assessment. Arterioscler. Thromb. Vasc. Bio.
19: 511-518
[Abstract][Full Text]
MURIN, S., MARELICH, G. P., ARROLIGA, A. C., MATTHAY, R. A.
(1998). Hereditary Thrombophilia and Venous Thromboembolism. Am. J. Respir. Crit. Care Med.
158: 1369-1373
[Abstract][Full Text]
Martinelli, I., Mannucci, P. M., De Stefano, V., Taioli, E., Rossi, V., Crosti, F., Paciaroni, K., Leone, G., Faioni, E. M.
(1998). Different Risks of Thrombosis in Four Coagulation Defects Associated With Inherited Thrombophilia: A Study of 150 Families. Blood
92: 2353-2358
[Abstract][Full Text]
Laffan, M.
(1998). Genetics and pulmonary medicine bullet 4: Pulmonary embolism. Thorax
53: 698-702
[Full Text]
Goldhaber, S. Z.
(1998). Pulmonary Embolism. NEJM
339: 93-104
[Full Text]
Goldhaber, S. Z
(1998). Clinical overview of venous thromboembolism. Vasc Med
3: 35-40
[Abstract]
Buller, H. R, Kraaijenhagen, R. A, Koopman, M. M.
(1998). Early discharge strategies following venous thrombosis. Vasc Med
3: 47-50
[Abstract]
Bick, R. L., Kaplan, H.
(1998). Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Thrombophilias. CLIN APPL THROMB HEMOST
4: 25-50
[Abstract]
Xu, N., Dahlback, B., Ohlin, A.-K., Nilsson, A.
(1998). Association of Vitamin K–Dependent Coagulation Proteins and C4b Binding Protein With Triglyceride-Rich Lipoproteins of Human Plasma. Arterioscler. Thromb. Vasc. Bio.
18: 33-39
[Abstract][Full Text]
PIERRE-JACQUES, H., GLUECK, C. J., MONT, M. A., HUNGERFORD, D. S.
(1997). Familial Heterozygous Protein-S Deficiency in a Patient Who Had Multifocal Osteonecrosis. A Case Report. JBJS
79: 1079-84
[Full Text]
Simmonds, R. E., Zoller, B., Ireland, H., Thompson, E., Garcia de Frutos, P., Dahlback, B., Lane, D. A.
(1997). Genetic and Phenotypic Analysis of a Large (122-Member) Protein S-Deficient Kindred Provides an Explanation for the Familial Coexistence of Type I and Type III Plasma Phenotypes. Blood
89: 4364-4370
[Abstract][Full Text]
Cadroy, Y., Diquelou, A., Dupouy, D., Bossavy, J.P., Sakariassen, K.S., Sie, P., Boneu, B.
(1997). The Thrombomodulin/Protein C/Protein S Anticoagulant Pathway Modulates the Thrombogenic Properties of the Normal Resting and Stimulated Endothelium. Arterioscler. Thromb. Vasc. Bio.
17: 520-527
[Abstract][Full Text]
Simioni, P., Prandoni, P., Lensing, A. W.A., Scudeller, A., Sardella, C., Prins, M. H., Villalta, S., Dazzi, F., Girolami, A.
(1997). The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506->Gln Mutation in the Gene for Factor V (Factor V Leiden). NEJM
336: 399-403
[Abstract][Full Text]
Prandoni, P., Polistena, P., Bernardi, E., Cogo, A., Casara, D., Verlato, F., Angelini, F., Simioni, P., Signorini, G. P., Benedetti, L., Girolami, A.
(1997). Upper-Extremity Deep Vein Thrombosis: Risk Factors, Diagnosis, and Complications. Arch Intern Med
157: 57-62
[Abstract]
Zoller, B., Hillarp, A., Dahlback, B.
(1997). State-of-the-Art Review: Activated Protein C Resistance: Clinical Implications. CLIN APPL THROMB HEMOST
3: 25-32
[Abstract]
Ginsberg, J. S.
(1996). Management of Venous Thromboembolism. NEJM
335: 1816-1829
[Full Text]
van den Belt, A. G. M., Prins, M. H., Huisman, M. V., Hirsh, J.
(1996). Familial Thrombophilia: A Review Analysis. CLIN APPL THROMB HEMOST
2: 227-236
[Abstract]
Hirsh, J., Hoak, J.
(1996). Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association. Circulation
93: 2212-2245
[Full Text]
Bauer, K.A., Graeme-Cook, F.M.
(1996). Case 12-1996- An 18-year-old woman with hepatomegaly and ascites. NEJM
334: 1045-1051
[Full Text]
Cogo, A., Lensing, A. W. A., Prandoni, P., Simioni, P., Bernardi, E., Girolami, B., Piccioli, A., Villalta, S., Wouter ten Cate, J., Girolami, A.
(1996). Relevance of Inherited Risk Factors in Young Patients with Deep-Vein Thrombosis. CLIN APPL THROMB HEMOST
2: 55-59
[Abstract]
Zanon, E., Saracino, M.A., Simioni, P., Cogo, A., Fadin, M.A., Gavasso, S., Girolami, A.
(1996). Prevalence of Antiphospholipid Antibodies and Lupus Anticoagulant in Juvenile Patients with Objectively Documented Deep-vein Thrombosis. CLIN APPL THROMB HEMOST
2: 69-73
[Abstract]
GLUECK, C. J., CRAWFORD, A., ROY, D., FREIBERG, R., GLUECK, H., STROOP, D.
(1996). Association of Antithrombotic Factor Deficiencies and Hypofibrinolysis with Legg-Perthes Disease. JBJS
78: 3-13
[Abstract][Full Text]
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., Miletich, J. P.
(1995). Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men. NEJM
332: 912-917
[Abstract][Full Text]
Baker, W. F. JR
(1995). Outcome Analysis for Treatment in 100 Patients with Deep Vein Thrombosis. CLIN APPL THROMB HEMOST
1: 39-48
[Abstract]
Svensson, P. J., Dahlback, B.
(1994). Resistance to Activated Protein C as a Basis for Venous Thrombosis. NEJM
330: 517-522
[Abstract][Full Text]
Bauer, K. A.
(1994). Hypercoagulability -- A New Cofactor in the Protein C Anticoagulant Pathway. NEJM
330: 566-567
[Full Text]
Cogo, A., Bernardi, E., Prandoni, P., Girolami, B., Noventa, F., Simioni, P., Girolami, A.
(1994). Acquired Risk Factors for Deep-Vein Thrombosis in Symptomatic Outpatients. Arch Intern Med
154: 164-168
[Abstract]
Hastings, G. E., Seery, D. S., Vine, D. L.
(1993). Recent Developments in the Diagnosis, Treatment, and Prevention of Pulmonary Embolism. Arch Fam Med
2: 655-669
[Abstract]
Previous
